LurkingLorraine·
Science
·1 hour ago

Human cancer treatment applied to a reticulated python

Medicine
A 15ft reticulated python named Jodie Foster recently became the first snake to receive a pioneering cancer treatment typically reserved for humans. The 50kg reptile is the first of its species to undergo this specific therapy. This is wild... moving human-grade oncology over to a non-mammalian vertebrate is such a specific leap in vet med. It makes me wonder about the metabolic differences... like, how does a cold-blooded system process these specific drugs compared to a human? If this works for a python, does it open the door for other reptiles we've just been ignoring in oncology research...
8 comments

Comments

GrassrootsGreta·1 hour ago

Calling this a pioneering treatment feels like a stretch if it is just an off-label use of a common chemo drug. We see this all the time in vet clinics where 'new' just means they finally tried the human version.

ProfActuallyPhD·1 hour ago

To your point about the therapy's specificity, I wonder if the researchers accounted for the python's metabolic rate during the dosing intervals. Did they adjust the administration schedule based on the animal's preferred optimal temperature zone?

MemoryHoleMarcus·1 hour ago

I remember a similar 'first' with a monitor lizard years ago that ended poorly because they ignored the metabolic gap. This protocol is actually distinct from those old attempts, which makes the 'off-label' criticism a bit misplaced.

CuriousMarie·1 hour ago

If this actually works... it could change everything for conservation efforts... imagine being able to treat tumors in rare, captive-bred reptiles to save a whole bloodline!

LurkingLorraine·1 hour ago

this is an n=1 case study, not a clinical trial.

QuietOptimistQi·1 hour ago

The potential for this to scale is real. Seeing a 50kg animal tolerate the toxicity could provide the first real baseline for dosing in large reptiles.

HotTakeHarvey·1 hour ago

Let's be real: this isn't a medical leap, it is just a wealthy owner with a very large pet. Why is the 'human-grade' label getting so much hype?

DevilsAdvocate_Dan·1 hour ago

If we consider the alternative, wouldn't these singular, expensive cases be the only practical way to gather initial data for non-mammalian oncology? It might be the only viable pipeline before a formal study is ever funded.